查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041840

神經刺激設備市場預測—全球產品類型、設備類型、疾病、應用、最終用戶和地區分析—2034年

Neurostimulation Devices Market Forecasts to 2034 - Global Analysis By Product (Closed-Loop Stimulation Systems, Deep Brain Stimulation and Other Products), By Device Type, Disease Pathology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球神經刺激設備市場預計到 2026 年將達到 113 億美元，並在預測期內以 13.3% 的複合年成長率成長，到 2034 年達到 308 億美元。

神經刺激設備是一種專門用於透過電刺激或化學方法調節神經系統活動的裝置。這些裝置可以植入體內或外用，作用於特定的神經或腦區。透過提供可控制的刺激，它們有助於控制慢性疼痛、運動障礙、癲癇和憂鬱症神經系統疾病，緩解症狀，並提高患者的生活品質。

根據癲癇中心發布的消息，目前全球整體約有 5,000 萬人患有癲癇，每年新增病例約 240 萬例。

慢性病盛行率增加

慢性疼痛症候群、帕金森氏症、癲癇症和難治性憂鬱症慢性疾病的日益普遍，是神經刺激設備市場的重要成長要素。神經刺激設備提供了一種創新的治療方法，能夠有效緩解症狀。隨著全球慢性疾病患者人數的增加，對先進的非藥物療法的需求也在不斷成長，從而推動了神經刺激設備作為有效治療方案的成長和應用。

高成本，保險覆蓋範圍有限。

這些先進設備需要大量的初始投資，這往往限制了患者的就醫途徑，並造成經濟障礙。此外，某些地區保險覆蓋範圍不足和報銷政策不完善，也限制了患者的支付能力和醫療機構的採納率。這種情況會減少患者數量和醫療機構的投資，進而影響市場成長，並減緩神經刺激設備的普及速度。

個人化醫療的進展

創新技術和精準醫療方法能夠提供更具針對性的干涉措施，滿足每位患者的個別需求。個人化治療充分考慮患者的解剖結構、神經反應、病情嚴重程度等因素，在提高療效的同時，也能減少副作用。這一趨勢不僅透過改善患者的治療效果和滿意度來推動市場成長，而且還加速了可自訂神經刺激設備的研發，滿足多樣化的患者需求，並擴大了市場的潛在覆蓋範圍。

各大公司之間的激烈競爭

主要企業之間的激烈競爭構成威脅，可能導致市場飽和和價格壓力。眾多公司爭奪市場佔有率，創新變得至關重要，現有技術可能很快就會過時。此外，旨在獲得競爭優勢的激進定價策略會影響盈利，並阻礙研發投入。這種主導環境也會推高行銷成本，阻礙中小企業發展，導致市場力量集中，並扼殺創新。

新冠疫情的影響：

新冠疫情擾亂了神經刺激設備市場，導致部分手術（包括設備植入手術）延誤。醫院收治能力下降以及醫療資源轉移至對抗疫情，導致治療延誤和設備部署放緩。供應鏈中斷和物流挑戰進一步影響了生產和分銷，削弱了神經刺激設備的供應，從而對疫情期間的市場成長產生了負面影響。

在預測期內，血栓除去裝置細分市場預計將成為最大的細分市場。

由於中風和血栓性疾病發病率不斷上升，腦血栓切除器械領域預計將成為市場成長的主要驅動力。血栓切除系統、抽吸裝置和勒除器技術的進步為清除腦動脈血栓提供了微創解決方案，這對於治療急性缺血性腦中風至關重要。人們日益認知到神經血栓切除術在改善患者預後方面的有效性，加上有利的醫療政策，預計將推動該領域顯著成長。這將滿足中風治療領域尚未滿足的需求，並有望在神經刺激器材市場中發揮關鍵作用。

預計在預測期內，憂鬱症市場板塊的複合年成長率將最高。

受公眾意識提升、患者群體不斷擴大以及對藥物難治性憂鬱症替代療法的需求成長的推動，憂鬱症細分市場預計將呈現最高的市場成長率。諸如深部腦部刺激 (DBS) 和經顱磁刺激 (TMS) 等神經調控技術的持續進步，在緩解憂鬱症症狀方面取得了令人矚目的成果。在人們對心理健康日益關注以及傾向於非藥物療法的背景下，預計憂鬱症細分市場在預測期內將經歷快速滲透和顯著的市場成長。

市佔率最大的地區：

北美憑藉其強大的醫療保健基礎設施、大量的研發投入以及對創新技術的早期應用，預計將佔據最大的市場佔有率。該地區匯集了許多市場主要參與者，並擁有優惠的報銷政策，這些因素正推動神經刺激療法的廣泛應用。此外，神經系統疾病盛行率的不斷上升，以及對慢性病積極主動的應對措施，使北美處於行業領先地位，推動了市場顯著成長，並在神經刺激設備行業佔據主導地位。

複合年成長率最高的地區：

預計歐洲將成為神經刺激設備市場複合年成長率最高的地區，這主要得益於醫療保健支出不斷成長、研發活動日益頻繁以及易患神經系統疾病的老年人口不斷增加。優惠的報銷政策和積極採用創新醫療技術的態度也進一步推動了這一成長。此外，醫療專業人員和患者對神經刺激設備益處的認知不斷提高，也促進了該地區市場的擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球神經刺激設備市場：依產品分類

  • 封閉回路型刺激系統
  • 深部腦部刺激（DBS）
  • 運動皮質刺激（MCS）
  • 薦椎神經刺激（SNS）
  • 脊髓刺激（SCS）
  • 三叉神經刺激（TNS）
  • 迷走神經刺激術（VNS）
  • 其他產品

第6章 全球神經刺激設備市場：依設備類型分類

  • 動脈瘤栓塞裝置
    • 栓塞線圈
      • 裸露可拆卸線圈
      • 塗層可拆線圈
    • 血液灌流裝置
    • 液態栓塞劑
  • 腦血管球囊成形術和支架置入系統
    • 球囊導管
    • 頸動脈支架
  • 神經血栓除去裝置
    • 血栓清除
    • 吸力/吸力裝置
    • 勒除器
  • 其他設備類型

第7章：全球神經刺激設備市場：依疾病和病理分類

  • 動靜脈畸形和瘻管
  • 頸動脈狹窄
  • 腦動脈瘤
  • 缺血性中風
  • 其他疾病

第8章 全球神經刺激設備市場：依應用分類

  • 憂鬱症
  • 肌張力不全症
  • 癲癇
  • 胃輕癱
  • 疼痛管理
  • 帕金森氏症
  • 震顫
  • 尿失禁和糞便失禁
  • 其他用途

第9章 全球神經刺激設備市場：依最終用戶分類

  • 醫院
  • 認知護理中心
  • 專科診所
  • 研究機構
  • 其他最終用戶

第10章 全球神經刺激設備市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第11章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Abbott Laboratories
  • Axonics Modulation Technologies
  • BioControl Medical
  • Boston Scientific Corporation
  • LivaNova
  • Mainstay Medical
  • Medtronic
  • Merck & Co., Inc
  • MicroTransponder
  • Neuronetics
  • NeuroPace
  • Nevro Corp
  • Nexeon MedSystems
  • Saluda Medical
  • Soterix Medical
  • SPR Therapeutics
  • Stimwave Technologies
  • Synapse Biomedical
  • Zynex Medical
Product Code: SMRC24906

According to Stratistics MRC, the Global Neurostimulation Devices Market is accounted for $11.3 billion in 2026 and is expected to reach $30.8 billion by 2034 growing at a CAGR of 13.3% during the forecast period. Neurostimulation devices are specialised instruments designed to modulate the nervous system's activity through electrical or chemical means. Implanted or applied externally, these devices target specific nerves or brain regions, managing neurological conditions like chronic pain, movement disorders, epilepsy, or depression by delivering controlled stimulation, aiding in symptom alleviation and enhancing the patient's quality of life.

According to the information distributed by the Epilepsy Center, by and by, around 50 million patients are living with epilepsy overall and around 2.4 million new cases are analyzed yearly.

Market Dynamics:

Driver:

Increasing prevalence of chronic disorders

The rising prevalence of chronic disorders, such as chronic pain syndromes and neurological conditions like Parkinson's disease, epilepsy and treatment-resistant depression, acts as a significant driver in the neurostimulation device market. Neurostimulation devices offer an innovative approach, providing effective symptom relief. With an increasing population affected by these chronic ailments globally, there's heightened demand for advanced, non-pharmacological treatments, propelling the growth and adoption of neurostimulation devices as viable therapeutic solutions.

Restraint:

High device costs and limited insurance coverage

The substantial initial investment required for these advanced devices often limits patient access, creating financial barriers. Additionally, inadequate insurance coverage or reimbursement policies in certain regions restrict patient affordability and healthcare provider adoption. This situation impacts market growth by reducing patient pool sizes and healthcare facility investments, slowing down the adoption rate of neurostimulation devices.

Opportunity:

Advancements in personalized treatment options

Tailoring therapies to individual patient needs through innovative technologies and precision medicine approaches allows for more targeted interventions. Personalised treatments, considering factors like patient anatomy, neural responses and condition severity, enhance efficacy while reducing adverse effects. This trend not only improves patient outcomes and satisfaction but also drives market growth by fostering the development of customisable neurostimulation devices, meeting the diverse needs of patients and expanding the market's potential reach.

Threat:

Intense competition among key players

Intense competition among key players poses a threat due to potential market saturation and pricing pressures. With multiple companies vying for market share, innovation becomes critical, potentially leading to the faster obsolescence of existing technologies. Moreover, aggressive pricing strategies to gain a competitive edge might impact profitability and hinder investment in research and development. This competition-driven environment may also elevate marketing costs and hinder smaller players' entry, consolidating market dominance and potentially stifling innovation.

Covid-19 Impact:

The COVID-19 pandemic disrupted the neurostimulation devices market by causing delays in elective surgeries, including device implantation procedures. Reduced hospital capacities and diverted healthcare resources towards managing the pandemic led to deferred treatments and slowed device adoption. Supply chain disruptions and logistical challenges further affected manufacturing and distribution, impacting the accessibility of neurostimulation devices and consequently affecting market growth during the pandemic period.

The neurothrombectomy devices segment is expected to be the largest during the forecast period

The neurothrombectomy devices segment is poised to dominate the market due to rising incidences of stroke and thrombotic conditions. Technological advancements in clot retrieval systems, suction devices and snares offer minimally invasive solutions for removing clots from cerebral arteries, vital in treating acute ischemic strokes. As awareness grows regarding the effectiveness of neurothrombectomy in improving patient outcomes, coupled with favorable reimbursement policies, this segment anticipates substantial growth, addressing an unmet need in stroke management and positioning itself as a pivotal player in the neurostimulation devices market.

The depression segment is expected to have the highest CAGR during the forecast period

The depression segment is projected to experience the highest growth rate in market due to increasing awareness, expanding patient populations and the demand for alternative treatments for medication-resistant depression. Continuous advancements in neuromodulation technologies, such as deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), offer promising outcomes in alleviating depressive symptoms. With a growing emphasis on mental health and a preference for non-pharmacological interventions, the depression segment is anticipated to witness rapid adoption and substantial market growth during the forecast period.

Region with largest share:

North America is set to secure the largest market share, due to its robust healthcare infrastructure, high investment in research and development and early adoption of innovative technologies. The region hosts prominent market players and enjoys favourable reimbursement policies, encouraging widespread adoption of neurostimulation therapies. Additionally, the increased prevalence of neurological disorders, coupled with a proactive approach towards addressing chronic conditions, positions North America at the forefront, driving substantial market growth and dominance in the neurostimulation devices industry.

Region with highest CAGR:

Europe is set to experience the highest CAGR in the neurostimulation devices market, owing to the increased healthcare expenditure, expanding R&D activities, and a growing geriatric population susceptible to neurological disorders. Favourable reimbursement policies and a proactive approach to adopting innovative medical technologies further contribute to this growth. Additionally, rising awareness among both healthcare providers and patients about the benefits of neurostimulation devices propels market expansion in the region.

Key players in the market

Some of the key players in Neurostimulation Devices Market include Abbott Laboratories, Axonics Modulation Technologies, BioControl Medical, Boston Scientific Corporation, LivaNova, Mainstay Medical, Medtronic, Merck & Co., Inc, MicroTransponder, Neuronetics, NeuroPace, Nevro Corp, Nexeon MedSystems, Saluda Medical, Soterix Medical, SPR Therapeutics, Stimwave Technologies, Synapse Biomedical and Zynex Medical.

Key Developments:

In May 2023, Abbott received FDA approval for its spinal cord stimulation (SCS) systems for treating chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back pain. This new indication applies to all Abbott's SCS products in the United States, including the Eterna SCS platform and the Proclaim SCS family.

In August 2022, Merck announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH, a B. Braun subsidiary, to develop a neurostimulator device that can complement the existing drug therapies of patients with chronic inflammatory diseases.

Products Covered:

  • Closed-Loop Stimulation Systems
  • Deep Brain Stimulation (DBS)
  • Motor Cortex Stimulation (MCS)
  • Sacral Nerve Stimulation (SNS)
  • Spinal Cord Stimulation (SCS)
  • Trigeminal Nerve Stimulation (TNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Products

Device Types Covered:

  • Aneurysm Coiling & Embolization Devices
  • Cerebral balloon angioplasty & Stenting systems
  • Neurothrombectomy Devices

Disease Pathologies Covered:

  • Arteriovenous Malformations and Fistulas
  • Carotid Artery Stenosis
  • Cerebral Aneuryms
  • Ischemic Strokes
  • Other Diseases

Applications Covered:

  • Depression
  • Dystonia
  • Epilepsy
  • Gastroparesis
  • Pain Management
  • Parkinson's Disease
  • Tremors
  • Urinary and Fecal Incontinence
  • Other Applications

End Users Covered:

  • Hospitals
  • Cognitive Care Centers
  • Specialty Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurostimulation Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Closed-Loop Stimulation Systems
  • 5.3 Deep Brain Stimulation (DBS)
  • 5.4 Motor Cortex Stimulation (MCS)
  • 5.5 Sacral Nerve Stimulation (SNS)
  • 5.6 Spinal Cord Stimulation (SCS)
  • 5.7 Trigeminal Nerve Stimulation (TNS)
  • 5.8 Vagus Nerve Stimulation (VNS)
  • 5.9 Other Products

6 Global Neurostimulation Devices Market, By Device Type

  • 6.1 Introduction
  • 6.2 Aneurysm Coiling & Embolization Devices
    • 6.2.1 Embolic Coils
      • 6.2.1.1 Bare Detachable Coils
      • 6.2.1.2 Coated Detachable Coils
    • 6.2.2 Flow Diversion Devices
    • 6.2.3 Liquid Embolic Agents
  • 6.3 Cerebral balloon angioplasty & Stenting systems
    • 6.3.1 Balloon Catheters
    • 6.3.2 Carotid Artery Stents
  • 6.4 Neurothrombectomy Devices
    • 6.4.1 Clot Retrievals
    • 6.4.2 Suction & Aspiration Devices
    • 6.4.3 Snares
  • 6.5 Other Device Types

7 Global Neurostimulation Devices Market, By Disease Pathology

  • 7.1 Introduction
  • 7.2 Arteriovenous Malformations and Fistulas
  • 7.3 Carotid Artery Stenosis
  • 7.4 Cerebral Aneuryms
  • 7.5 Ischemic Strokes
  • 7.6 Other Diseases

8 Global Neurostimulation Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Depression
  • 8.3 Dystonia
  • 8.4 Epilepsy
  • 8.5 Gastroparesis
  • 8.6 Pain Management
  • 8.7 Parkinson's Disease
  • 8.8 Tremors
  • 8.9 Urinary and Fecal Incontinence
  • 8.10 Other Applications

9 Global Neurostimulation Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Cognitive Care Centers
  • 9.4 Specialty Clinics
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Neurostimulation Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Axonics Modulation Technologies
  • 12.3 BioControl Medical
  • 12.4 Boston Scientific Corporation
  • 12.5 LivaNova
  • 12.6 Mainstay Medical
  • 12.7 Medtronic
  • 12.8 Merck & Co., Inc
  • 12.9 MicroTransponder
  • 12.10 Neuronetics
  • 12.11 NeuroPace
  • 12.12 Nevro Corp
  • 12.13 Nexeon MedSystems
  • 12.14 Saluda Medical
  • 12.15 Soterix Medical
  • 12.16 SPR Therapeutics
  • 12.17 Stimwave Technologies
  • 12.18 Synapse Biomedical
  • 12.19 Zynex Medical

List of Tables

  • Table 1 Global Neurostimulation Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Neurostimulation Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Neurostimulation Devices Market Outlook, By Closed-Loop Stimulation Systems (2023-2034) ($MN)
  • Table 4 Global Neurostimulation Devices Market Outlook, By Deep Brain Stimulation (DBS) (2023-2034) ($MN)
  • Table 5 Global Neurostimulation Devices Market Outlook, By Motor Cortex Stimulation (MCS) (2023-2034) ($MN)
  • Table 6 Global Neurostimulation Devices Market Outlook, By Sacral Nerve Stimulation (SNS) (2023-2034) ($MN)
  • Table 7 Global Neurostimulation Devices Market Outlook, By Spinal Cord Stimulation (SCS) (2023-2034) ($MN)
  • Table 8 Global Neurostimulation Devices Market Outlook, By Trigeminal Nerve Stimulation (TNS) (2023-2034) ($MN)
  • Table 9 Global Neurostimulation Devices Market Outlook, By Vagus Nerve Stimulation (VNS) (2023-2034) ($MN)
  • Table 10 Global Neurostimulation Devices Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 11 Global Neurostimulation Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 12 Global Neurostimulation Devices Market Outlook, By Aneurysm Coiling & Embolization Devices (2023-2034) ($MN)
  • Table 13 Global Neurostimulation Devices Market Outlook, By Embolic Coils (2023-2034) ($MN)
  • Table 14 Global Neurostimulation Devices Market Outlook, By Bare Detachable Coils (2023-2034) ($MN)
  • Table 15 Global Neurostimulation Devices Market Outlook, By Coated Detachable Coils (2023-2034) ($MN)
  • Table 16 Global Neurostimulation Devices Market Outlook, By Flow Diversion Devices (2023-2034) ($MN)
  • Table 17 Global Neurostimulation Devices Market Outlook, By Liquid Embolic Agents (2023-2034) ($MN)
  • Table 18 Global Neurostimulation Devices Market Outlook, By Cerebral balloon angioplasty & Stenting systems (2023-2034) ($MN)
  • Table 19 Global Neurostimulation Devices Market Outlook, By Balloon Catheters (2023-2034) ($MN)
  • Table 20 Global Neurostimulation Devices Market Outlook, By Carotid Artery Stents (2023-2034) ($MN)
  • Table 21 Global Neurostimulation Devices Market Outlook, By Neurothrombectomy Devices (2023-2034) ($MN)
  • Table 22 Global Neurostimulation Devices Market Outlook, By Clot Retrievals (2023-2034) ($MN)
  • Table 23 Global Neurostimulation Devices Market Outlook, By Suction & Aspiration Devices (2023-2034) ($MN)
  • Table 24 Global Neurostimulation Devices Market Outlook, By Snares (2023-2034) ($MN)
  • Table 25 Global Neurostimulation Devices Market Outlook, By Disease Pathology (2023-2034) ($MN)
  • Table 26 Global Neurostimulation Devices Market Outlook, By Arteriovenous Malformations and Fistulas (2023-2034) ($MN)
  • Table 27 Global Neurostimulation Devices Market Outlook, By Carotid Artery Stenosis (2023-2034) ($MN)
  • Table 28 Global Neurostimulation Devices Market Outlook, By Cerebral Aneuryms (2023-2034) ($MN)
  • Table 29 Global Neurostimulation Devices Market Outlook, By Ischemic Strokes (2023-2034) ($MN)
  • Table 30 Global Neurostimulation Devices Market Outlook, By Other Diseases (2023-2034) ($MN)
  • Table 31 Global Neurostimulation Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 32 Global Neurostimulation Devices Market Outlook, By Depression (2023-2034) ($MN)
  • Table 33 Global Neurostimulation Devices Market Outlook, By Dystonia (2023-2034) ($MN)
  • Table 34 Global Neurostimulation Devices Market Outlook, By Epilepsy (2023-2034) ($MN)
  • Table 35 Global Neurostimulation Devices Market Outlook, By Gastroparesis (2023-2034) ($MN)
  • Table 36 Global Neurostimulation Devices Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 37 Global Neurostimulation Devices Market Outlook, By Parkinson's Disease (2023-2034) ($MN)
  • Table 38 Global Neurostimulation Devices Market Outlook, By Tremors (2023-2034) ($MN)
  • Table 39 Global Neurostimulation Devices Market Outlook, By Urinary and Fecal Incontinence (2023-2034) ($MN)
  • Table 40 Global Neurostimulation Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 41 Global Neurostimulation Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 42 Global Neurostimulation Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 43 Global Neurostimulation Devices Market Outlook, By Cognitive Care Centers (2023-2034) ($MN)
  • Table 44 Global Neurostimulation Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 45 Global Neurostimulation Devices Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 46 Global Neurostimulation Devices Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.